Sign in

CIK 0001604821

  • Large accelerated filer

Natera, Inc.

Sign in to watch
Ticker
NTRA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
010894487
Phone
+1 650-249-9090
Business address
13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
Former names
Natera, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$104,832,418
in 28 filings, $104.8M under 10b5-1 plans

Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-03-05 Sheena Jonathan Director Sale 10b5-1 −1,028 $88.37 $91K 463,585
2024-03-05 RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Sale −2,160 $88.37 $191K 204,218
2024-03-05 Chapman Steven Leonard CEO AND PRESIDENT Sale −9,326 $88.37 $824K 246,957
2024-03-05 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sale −2,826 $88.37 $250K 70,646
2024-03-05 Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Sale −18 $87.33 $2K 200,494
2024-03-05 Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Sale −2,227 $88.37 $197K 198,267
2024-03-05 Fesko John PRESIDENT, CHIEF BUS. OFFICER Sale −15 $87.37 $1K 114,486
2024-03-05 Fesko John PRESIDENT, CHIEF BUS. OFFICER Sale −1,823 $88.37 $161K 112,663
2024-03-05 Rabinowitz Matthew EXECUTIVE CHAIRMAN Sale 10b5-1 −8 $87.25 $698 1,076,652
2024-03-05 Rabinowitz Matthew EXECUTIVE CHAIRMAN Sale 10b5-1 −1,004 $88.37 $89K 1,075,648
2024-03-05 Rabinowitz Matthew EXECUTIVE CHAIRMAN Sale 10b5-1 −73,788 $86.88 $6.4M 976,248
2024-03-05 Rabinowitz Matthew EXECUTIVE CHAIRMAN Sale 10b5-1 −96,977 $87.49 $8.5M 879,271
2024-03-05 Rabinowitz Matthew EXECUTIVE CHAIRMAN Sale 10b5-1 −13,743 $88.64 $1.2M 865,528
2024-03-05 Rabinowitz Matthew EXECUTIVE CHAIRMAN Sale 10b5-1 −5,492 $89.40 $491K 860,036
2024-03-01 Sheena Jonathan Director Grant or award +1,028 464,613
2024-03-01 Rabinowitz Matthew EXECUTIVE CHAIRMAN Grant or award +4,104 1,076,660
2024-03-01 RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Grant or award +2,160 206,378
2024-03-01 Chapman Steven Leonard CEO AND PRESIDENT Grant or award +9,326 256,283
2024-03-01 Brophy Michael Burkes CHIEF FINANCIAL OFFICER Grant or award +2,826 73,472
2024-03-01 Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Grant or award +2,329 197,306

Page 78 of 85 · 1,682 trades